The transaction is structured in two tranches: a €2.5 million non-dilutive grant awarded by CDTI under the European Innovation Council (EIC) Seal of Excellence, and the closing of a €500,000 priva...
Clinical trials are among biopharma’s most significant investments, yet many still advance on internal optimism rather than external validation. In contrast, private equity (PE) firms apply structur...
The Smart Lollipop was founded in November 2020 as a Spanish deeptech startup with a very clear objective: to develop non-invasive, agile and digital medical diagnostic solutions that improve the clin...
In the Iberian market, growth has been driven mainly by increased foreign investment inflows. Over the past year, international groups have entered various segments of the value chain, ranging from cl...
Biotasmart is a Lanzadera-accelerated startup that has positioned itself as a benchmark in translating the scientific complexity of the microbiota into personalized clinical recommendations that can b...
In the area of investment and operational support, GENESIS Biomed maintains two managed vehicles, with €3.5M associated and a total of 20 investments made, reinforcing an end-to-end vision that comb...
The Healthcare sector remains one of the most resilient engines of the European M&A market, despite a 2025 marked by increased macroeconomic uncertainty. According to the Healthcare Update Q4 2025, Sp...
For years, oncology drug launches relied on standardized approaches. But tightening price controls, fiercer competition, and fast-evolving markets are challenging this model. Creating sustainable valu...
The forum Invertir en Ciencia Sí es Rentable has recognized the Galician company Centum and the Catalan biotech ecosystem Biocat for their contribution to the development of innovation in health and ...
The alliance is conceived as an open collaboration platform designed to connect the various actors in the healthcare system —industry, care providers, research institutions, public administration, a...
Endor Technologies is advancing the development of an innovative treatment for metastatic tumors based on a therapeutic paradigm shift. With the support of CDTI Innovación funding and co-financing fr...
This initiative will enable Ysios Capital to work more closely with universities, research centers and scientific entrepreneurs to identify innovative biomedical opportunities and support their develo...
